What is Psyched Wellness?
Psyched Wellness operates at the intersection of biotechnology and consumer health, specializing in the research, development, and distribution of products derived from the Amanita Muscaria mushroom. The company's flagship offering, Calm, represents a significant innovation in the natural sleep aid market, utilizing a patented decarboxylation process to ensure safety and efficacy for end-users. By prioritizing preclinical trials and ethical sourcing, the firm distinguishes itself as a science-led entity in a market often crowded with unregulated alternatives.
The company's business model is anchored by its retail outlet, which serves as a direct-to-consumer channel for its micro-serving extracts. This vertical integration allows Psyched Wellness to maintain strict quality control while gathering valuable consumer insights, which are essential for refining their product pipeline and maintaining a competitive edge in the rapidly evolving wellness landscape.
How much funding has Psyched Wellness raised?
Psyched Wellness has raised a total of $3.6M across 3 funding rounds:
Share Placement
$2.5M
Stock/Share Issuance
$627K
Stock/Share Issuance
$449K
Share Placement (2024): $2.5M, investors not publicly disclosed
Stock/Share Issuance (2026): $627K, investors not publicly disclosed
Stock/Share Issuance (2026): $449K, investors not publicly disclosed
Key Investors in Psyched Wellness
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Psyched Wellness?
Looking ahead, the strategic deployment of the $627K will likely focus on scaling manufacturing capacity and broadening market reach. As the company navigates the complexities of the life science industry, the focus will remain on regulatory compliance and the expansion of its product portfolio. Investors are closely monitoring the firm's ability to translate its scientific research into sustained revenue growth, particularly as it seeks to capture a larger share of the natural relaxation and sleep-quality market. The company's commitment to innovation suggests a long-term strategy centered on establishing a dominant position in the botanical wellness sector.
See full Psyched Wellness company page
